Determination of pyridoxal 5'-phosphate in human serum by reversed phase high performance liquid chromatography combined with spectrofluorimetric detection of 4-pyridoxic acid 5'-phosphate as a derivative.
A very sensitive spectrofluorimetric method for the determination of pyridoxal 5'-phosphate (PLP) in human serum is described. The specificity is based on the selective oxidation of PLP to 4-pyridoxic acid 5'-phosphate with potassium cyanide. Separation of the highly fluorescent 4-pyridoxic acid 5'-phosphate is achieved by reversed-phase high-performance liquid chromatography. Specificity is improved by a careful choice of fluorescence filters, maximised at the excitation (325 nm) and emission (418 nm) wavelengths of 4-pyridoxic acid 5'-phosphate. The detection limit for the reaction is 0.22 ng ml(-1). For quantification, the serum is spiked with PLP before protein precipitation with 3.3% m/V trichloroacetic acid. The method can be used for the determination of PLP in serum, even in vitamin B6 deficient patients. The mean value for human serum PLP from 30 healthy adults was found to be 14.6 +/- 4.8 ng ml(-1) (mean +/- standard deviation).
Millart
H
H
Lamiable
D
D
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007539:Isonicotinic Acids / Q000097:blood*; D011732:Pyridoxal Phosphate / Q000097:blood*; D011735:Pyridoxic Acid / Q000031:analogs & derivatives / Q000097:blood*; D013050:Spectrometry, Fluorescence
D007539:Isonicotinic Acids; D011735:Pyridoxic Acid; D011732:Pyridoxal Phosphate; C062598:4-pyridoxic acid 5'-phosphate